LeddarTech et Prospector Capital Corp. annoncent l’entrée en vigueur de la déclaration d’enregistrement et la tenue d’une assemblée générale extraordinaire le 13 décembre 2023 visant l’approbation du regroupement d’entreprises
QUÉBEC, 04 déc. 2023 (GLOBE NEWSWIRE) — More >>
LeddarTech and Prospector Capital Corp. Announce Effectiveness of Registration Statement and December 13, 2023 Extraordinary General Meeting to Approve Business Combination
QUEBEC CITY, Dec. 04, 2023 (GLOBE NEWSWIRE) — LeddarTech... More >>
Climate Action Forum: Indiaspora Convenes Climate Experts at COP 28
WASHINGTON and DELHI, India, Dec. 04, 2023 (GLOBE NEWSWIRE) — More >>
Zenas BioPharma Fortalece a Liderança Executiva com a Nomeação de Jennifer Fox como Diretora de Negócios e Financeira, e de Tanya Fischer, MD, Ph.D. como Dirigente de P&D e Médica
WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) — A Zenas BioPharma, uma empresa biofarmacutica global comprometida em se tornar lder no desenvolvimento e comercializao de terapias voltadas para inflamaes e imunologia (I&I), divulgou hoje a nomeao de... More >>
Zenas BioPharma stärkt seine Führungsspitze mit der Ernennung von Jennifer Fox als Chief Business Officer und Chief Financial Officer sowie von Tanya Fischer, M.D., PhD. als Leiterin von Forschung und Entwicklung und als Chief Medical Officer
WALTHAM, Massachusetts, Dec. 04, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, ein weltweit ttiges Biopharmazieunternehmen, das sich der Aufgabe verschrieben hat, eine fhrende Position in der Entwicklung und Vermarktung von zielgerichteten Therapien fr die... More >>
Zenas BioPharma renforce sa direction avec la nomination de Jennifer Fox en tant que Chief Business Officer et Chief Financial Officer et de Tanya Fischer, M.D., PhD., en tant que Head of R&D et Chief Medical Officer
WALTHAM, Massachusetts, 04 déc. 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, un laboratoire biopharmaceutique d'envergure mondiale dtermin devenir un leader dans le dveloppement et la commercialisation de traitements dans les domaines de... More >>
Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer
WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I&I) directed therapies, today... More >>
More >> A Climate Scientist’s View of COP 28
Research team in the Arctic. Professor... More >> 
Euro Exchange Rate